Prophylaxis of mould infections

Invasive fungal infection continues to be an important cause of morbidity and mortality in haematological patients. Antifungal prophylaxis in these patients has remarkably increased survival since its introduction. In recent years, new antifungals have been on the rise, being more effective and havi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-García, Estela, Chumbita, Mariana, Puerta-Alcalde, Pedro, Cardozo, Celia, Garcia-Vidal, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Update on the Infection of the Immunocompromised Patient
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755369/
https://www.ncbi.nlm.nih.gov/pubmed/31475813
_version_ 1783453219224027136
author Moreno-García, Estela
Chumbita, Mariana
Puerta-Alcalde, Pedro
Cardozo, Celia
Garcia-Vidal, Carolina
author_facet Moreno-García, Estela
Chumbita, Mariana
Puerta-Alcalde, Pedro
Cardozo, Celia
Garcia-Vidal, Carolina
author_sort Moreno-García, Estela
collection PubMed
description Invasive fungal infection continues to be an important cause of morbidity and mortality in haematological patients. Antifungal prophylaxis in these patients has remarkably increased survival since its introduction. In recent years, new antifungals have been on the rise, being more effective and having less toxicity than previous ones. Nonetheless, the number of patients at risk of fungal infection has also been increasing due to the continuous appearance of new immunosuppressive treatments. As a result of such, we face a changing situation that requires constant updating.
format Online
Article
Text
id pubmed-6755369
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-67553692019-10-04 Prophylaxis of mould infections Moreno-García, Estela Chumbita, Mariana Puerta-Alcalde, Pedro Cardozo, Celia Garcia-Vidal, Carolina Rev Esp Quimioter Update on the Infection of the Immunocompromised Patient Invasive fungal infection continues to be an important cause of morbidity and mortality in haematological patients. Antifungal prophylaxis in these patients has remarkably increased survival since its introduction. In recent years, new antifungals have been on the rise, being more effective and having less toxicity than previous ones. Nonetheless, the number of patients at risk of fungal infection has also been increasing due to the continuous appearance of new immunosuppressive treatments. As a result of such, we face a changing situation that requires constant updating. Sociedad Española de Quimioterapia 2019-09-01 2019 /pmc/articles/PMC6755369/ /pubmed/31475813 Text en © The Author 2019 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Update on the Infection of the Immunocompromised Patient
Moreno-García, Estela
Chumbita, Mariana
Puerta-Alcalde, Pedro
Cardozo, Celia
Garcia-Vidal, Carolina
Prophylaxis of mould infections
title Prophylaxis of mould infections
title_full Prophylaxis of mould infections
title_fullStr Prophylaxis of mould infections
title_full_unstemmed Prophylaxis of mould infections
title_short Prophylaxis of mould infections
title_sort prophylaxis of mould infections
topic Update on the Infection of the Immunocompromised Patient
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755369/
https://www.ncbi.nlm.nih.gov/pubmed/31475813
work_keys_str_mv AT morenogarciaestela prophylaxisofmouldinfections
AT chumbitamariana prophylaxisofmouldinfections
AT puertaalcaldepedro prophylaxisofmouldinfections
AT cardozocelia prophylaxisofmouldinfections
AT garciavidalcarolina prophylaxisofmouldinfections

Ejemplares similares